Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ADTX

Aditxt (ADTX)

Aditxt Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADTX
DateTimeSourceHeadlineSymbolCompany
05/22/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
05/20/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADTXAditxt Inc
05/15/20246:50AMPR Newswire (US)Evofem Biosciences Announces Financial Results for the First Quarter of 2024NASDAQ:ADTXAditxt Inc
05/13/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
05/08/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
05/07/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
05/03/20242:14PMBusiness WireCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
05/03/20249:00AMBusiness WireAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
04/02/20248:30AMBusiness WireAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)NASDAQ:ADTXAditxt Inc
03/27/20248:36AMPR Newswire (US)Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023NASDAQ:ADTXAditxt Inc
03/11/20244:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
03/07/20247:54AMPR Newswire (US)For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyNASDAQ:ADTXAditxt Inc
03/04/20245:27PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
03/04/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
03/01/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/29/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/22/20245:21PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
02/21/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/16/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/15/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/14/20249:26AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADTXAditxt Inc
02/09/20244:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/06/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/02/20244:28PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
02/02/20244:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/01/20248:00AMPR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023NASDAQ:ADTXAditxt Inc
01/30/20245:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/30/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/30/20248:30AMBusiness WireAditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology ApplicationsNASDAQ:ADTXAditxt Inc
01/23/20244:18PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADTXAditxt Inc
 Showing the most relevant articles for your search:NASDAQ:ADTX